Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ukrainskyj SM"'
Autor:
Savona MR; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Kolibaba K; US Oncology Research, Woodlands, Texas.; Northwest Cancer Specialists, Vancouver, Western Australia., Conkling P; US Oncology Research, Woodlands, Texas.; Virginia Oncology Associates, Norfolk, Virginia., Kingsley EC; US Oncology Research, Woodlands, Texas.; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada., Becerra C; US Oncology Research, Woodlands, Texas.; Texas Oncology, PA (North), Sammons Cancer Center, Dallas, Texas., Morris JC; University of Cincinnati Cancer Institute, Cincinnati, Ohio., Rifkin RM; US Oncology Research, Woodlands, Texas.; Rocky Mountain Cancer Centers, Denver, Colorado., Laille E; Celgene Corporation, Summit, New Jersey., Kellerman A; Celgene Corporation, Summit, New Jersey., Ukrainskyj SM; Celgene Corporation, Summit, New Jersey., Dong Q; Celgene Corporation, Summit, New Jersey., Skikne BS; Celgene Corporation, Summit, New Jersey.
Publikováno v:
American journal of hematology [Am J Hematol] 2018 Oct; Vol. 93 (10), pp. 1199-1206. Date of Electronic Publication: 2018 Sep 03.
Autor:
Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: ggarciam@mdanderson.org., Scott BL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Cogle CR; Medicine/Hematology & Oncology, University of Florida, Gainesville, FL, United States., Boyd TE; Willamette Valley Cancer Institute, Eugene, OR, United States., Kambhampati S; University of Kansas Medical Center, Kansas City, KS, United States; Sarah Cannon at Research Medical Center, Kansas City, MO, United States., Hetzer J; Celgene Corporation, Summit, NJ, United States., Dong Q; Celgene Corporation, Summit, NJ, United States., Kumar K; Celgene Corporation, Summit, NJ, United States., Ukrainskyj SM; Celgene Corporation, Summit, NJ, United States., Beach CL; Celgene Corporation, Summit, NJ, United States., Skikne BS; Celgene Corporation, Summit, NJ, United States.
Publikováno v:
Leukemia research [Leuk Res] 2018 Sep; Vol. 72, pp. 79-85. Date of Electronic Publication: 2018 Aug 03.